These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1583292)

  • 1. [Hyperplastic lesions of the high risk breast. Definitions, diagnostic and therapeutic problems].
    Scali P; Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):155-62. PubMed ID: 1583292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrocystic changes.
    Fiorica JV
    Obstet Gynecol Clin North Am; 1994 Sep; 21(3):445-52. PubMed ID: 7816405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer in women with benign breast disease.
    Hutchinson WB; Thomas DB; Hamlin WB; Roth GJ; Peterson AV; Williams B
    J Natl Cancer Inst; 1980 Jul; 65(1):13-20. PubMed ID: 6930509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrocystic breast disease--breast cancer sequence].
    Habor V; Habor A; Copotoiu C; Panţîru A
    Chirurgia (Bucur); 2010; 105(2):191-4. PubMed ID: 20540231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer: epidemiology, risk factors, screening].
    Gairard B; Mathelin C; Schaffer P; Brettes JP
    Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-risk breast lesions].
    Bild E
    Rev Med Chir Soc Med Nat Iasi; 1998; 102(1-2):29-35. PubMed ID: 10756809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.
    Cahn MD; Tran T; Theur CP; Butler JA
    Am Surg; 1997 Oct; 63(10):858-60. PubMed ID: 9322657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of breast lesions among women with positive biopsy findings in Yemen.
    Al-Thobhani AK; Raja'a YA; Noman TA; Al-Romaimah MA
    East Mediterr Health J; 2006 Sep; 12(5):599-604. PubMed ID: 17333799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is breast cancer prevention by tamoxifen possible?].
    Namer M; Serin D; Ferrero JM
    Bull Cancer; 1995 Jul; 82 Suppl 3():155s-167s. PubMed ID: 7492828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective studies on the relation between fibrocystic disease and cancer of the breast with therapeutic conclusions].
    Georgescu T; Naftali Z; Simu G; Nistor V; Crăciu C; Ilniczky P; Boţianu A; Răibuleţ M
    Chirurgia (Bucur); 1992; 41(1):10-8. PubMed ID: 1361381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and screening for breast cancer.
    Harper GR; Englisbe BH
    Cancer Detect Prev; 1993; 17(4-5):551-5. PubMed ID: 8242657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of risk factors in counseling patients.
    Love SM
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):599-610. PubMed ID: 2691491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
    Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.
    Page DL; Dupont WD; Rogers LW
    Cancer Detect Prev; 1986; 9(5-6):441-8. PubMed ID: 3779706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anatomopathological problems of mastopathies at risk].
    Contesso G; Mathieu MC; Guinebretière JM; Zemoura L; Bertin F; Petit JY; Lê M
    Arch Anat Cytol Pathol; 1994; 42(5):211-6. PubMed ID: 7872812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis.
    El Saghir NS; Khalil MK; Eid T; El Kinge AR; Charafeddine M; Geara F; Seoud M; Shamseddine AI
    Int J Surg; 2007 Aug; 5(4):225-33. PubMed ID: 17660128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.